Used in pharmaceutical research as a key intermediate in the synthesis of selective receptor modulators, particularly for neurological targets. Shows potential in the development of agents affecting central nervous system disorders due to its structural affinity with monoamine receptors. Also employed in the study of metabolic stability and bioavailability of fused-ring amide compounds. Investigated for anti-inflammatory properties in preclinical models.